Testosterone modulation of default mode network and its effects on cognitive function and mood in humans: a systematic review Daria Malich, Andrii Vasylyshyn Abstract Testosterone exerts widespread effects on brain structure and function, yet its influence on large-scale neural networks, particularly the default mode network (DMN), remains poorly understood. The role of the DMN in self-referential processing, social cognition, and mood regulation has been demonstrated over the last decade. Neuroimaging studies suggest a link between testosterone and large-scale brain networks, particularly the DMN, in cognitive function and mood domains. A systematic search of the PubMed database was conducted from March to April 2026, restricted to human neuroimaging studies published within the past 15 years, in accordance with PRISMA guidelines. A total of 10 studies were included in this review. Risk of bias was assessed using RoB 2, the Newcastle–Ottawa Scale, the NIH Quality Assessment Tool, and the AXIS tool, selected according to study design. Testosterone-related DMN alterations were observed across key self-referential hubs, including the medial prefrontal cortex, anterior cingulate cortex, precuneus, and angular gyrus. Effects were highly sex-specific, developmental stage-dependent, and sensitive to the form and magnitude of androgen exposure. Testosterone levels were mostly linked to changes in affective reactivity and self-referential processing, including aggression modulation and body self-identification. Overall, testosterone-related modulation of DMN connectivity appears to be highly context dependent, with functional consequences predominantly affecting self-referential and affective domains rather than externally oriented cognition. The high heterogeneity of the included studies, alongside the absence of wider hormonal profiling in many studies, constrains causal inference. Future research should prioritize randomized longitudinal designs with comprehensive hormonal assessment and balanced sex representation to clarify the therapeutic relevance of testosterone-related DMN modulation. Introduction Testosterone is a sex hormone crucial for maintaining healthy reproductive function among males and females. However, over recent decades, growing evidence has demonstrated the vital role of sex hormones in a wide range of cognitive functions, including episodic memory, attention, executive function, and self-referential thinking (; ; ). Moreover, sex hormones, such as estradiol and testosterone, which are present in both males and females at different concentrations, have been shown to directly influence neural architecture across the lifespan (; ). Via androgen receptors distributed throughout the nervous system, testosterone modulates synaptic plasticity and may contribute to disorders, including Alzheimer's disease (AD), schizophrenia, and autism spectrum disorder (). A growing body of evidence has shown a link between endogenous testosterone levels and verbal fluency, visuospatial ability, episodic memory, and executive function performance (; ). In a large-scale study of elderly men, testosterone levels were associated with processing speed, sustained attention, and working memory, suggesting that declining bioavailable testosterone levels are correlated with an increased risk of cognitive impairment and dementia (). A substantial proportion of testosterone's central effects are mediated through aromatization to estradiol by the enzyme aromatase, which is highly expressed in cortical and limbic regions (). Therefore, the neural effects attributed to testosterone should be considered within the broader hormonal environment rather than in isolation (). Supporting this concept, dense-sampling neuroimaging studies have shown that day-to-day fluctuations in estradiol are associated with reorganization of large-scale cortical networks, with particularly pronounced effects in regions overlapping the DMN (). Dopaminergic signaling in the mesolimbic and mesocortical pathways is modulated through the effects of testosterone on androgen receptors localized across key dopaminergic circuit areas, such as the nucleus accumbens and ventral tegmental area, which are known for their functions in reward processing, motivation, and executive control (). Additionally, testosterone has been reported to contribute to alterations in excitation-inhibition homeostasis in the hippocampus and prefrontal cortex through modulation of GABAergic signaling via GABA-A receptors and glutamatergic transmission via NMDA receptors (; ). A negative correlation between testosterone levels and serotonin 4 receptor binding, particularly in the hippocampus, was found, indicating the important role of testosterone in serotonergic signaling (). Recent evidence suggests that cognitive and affective processes, such as self-referential thought, executive control, and mood regulation, are not localized to a single structure and instead emerge from the coordinated activity of distributed, whole-brain functional networks (; ). DMN connectivity has been directly linked to individual differences in cognitive functioning across development and aging, supporting network-level connectivity as a meaningful unit of analysis for understanding testosterone-related neurocognitive effects (). Therefore, examining large-scale brain networks may provide a promising framework for identifying the mechanisms of interaction between testosterone and cognition/mood domains. Several studies have shown that complex large-scale functional network interactions in the brain underlie cognitive functions and behavior (; ). Emerging neuroimaging evidence from a placebo-controlled resting-state fMRI study of 96 healthy men has shown that exogenous testosterone administration resulted in disruption of fronto-subcortical and fronto-parietal connectivity (). Moreover, sex-specific patterns of amygdala–frontal resting-state connectivity involved in cognitive control were predicted using endogenous testosterone levels (). In transgender men undergoing testosterone therapy, longitudinal changes in functional brain network connectivity, including shifts in affective and salience circuits following treatment, were reported (; ). The default mode network (DMN) is a functional brain network responsible for self-reflection and mental exploration, serving a critical role in brain development (). The DMN includes structures such as the medial prefrontal cortex, posterior cingulate cortex, precuneus, and angular gyrus, interconnected into one large-scale brain network (). A central role of the DMN in social cognition, prospective thinking, and mind-wandering has now been well established (). Moreover, the DMN has been reported as one network within the triple-network model, which also consists of the salience network and frontoparietal network (; ). The salience network functions as a dynamic switch that modulates transitions between internally directed processes conducted by the DMN and externally oriented processes conducted by the frontoparietal network (; ; ). Intracranial recordings provide direct evidence that the anterior insula, the central hub of the salience network, exerts task-dependent influence over both the DMN and frontoparietal network, thereby coordinating the balance between internally and externally oriented processing (). Several of the cognitive and affective functions, including affective reactivity, threat appraisal, and working memory, are therefore unlikely to depend on the DMN in isolation and instead appear to rely on its dynamic interplay with the salience and frontoparietal networks. DMN connectivity alterations have been documented in Alzheimer's disease, major depressive disorder, and schizophrenia, underscoring its critical function in mood and cognition (; ). DMN activity dysregulation has been identified as a consistent correlate of mood disturbance across clinical and subclinical populations (). Pathological over-engagement of the DMN reflects disruption of balance within the triple-network model, resulting in failure of the healthy anticorrelated relationship between the DMN and the frontoparietal network, and correlates directly with depressive symptom severity (). Another systematic review found a positive effect of antidepressant treatment, showing normalization of DMN hyperconnectivity over time (). Collectively, these findings suggest that DMN connectivity impairment may be a transdiagnostic neural mechanism underlying mood dysregulation, with potential as a biomarker for therapeutic monitoring (). Among the three large-scale brain networks included in the triple-network model, the DMN was selected as the focus of the present review due to its well-established role in self-referential processing and affect regulation (). In contrast, the frontoparietal network primarily supports externally directed cognitive control and attention-demanding tasks, whereas the salience network is responsible for detecting behaviourally relevant stimuli and coordinating dynamic switching between the DMN and frontoparietal network (; ). Testosterone has also been implicated in several processes associated with DMN function, including self-perception, threat appraisal and aggression regulation (). Therefore, the overlap between the functional role of the DMN and the reported effects of testosterone provides a rationale for focusing on the DMN as a potential mediator of testosterone-related changes in cognition and mood. The existing evidence provides a strong neurotransmitter-based mechanism of testosterone function in mood and cognition (). However, the growing amount of data indicates network-based involvement in cognition (). Therefore, the present review focuses primarily on the role of testosterone in modulating DMN connectivity and its potential implications for self-referential processing and affective reactivity, while also discussing broader cognitive outcomes where evidence is available. Materials and methods This systematic review adhered to the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) (). The review has been registered at PROSPERO (CRD420261368147). Search strategy PubMed was used to identify and screen relevant studies for this review. The initial search was conducted from March 2026 through April 2026 and was restricted to human studies published after 2011, within the last 15 years, and written in English. The following keywords were used for the database search: (testosterone OR “exogenous testosterone” OR “testosterone administration” OR “testosterone supplementation” OR “testosterone therapy” OR “testosterone replacement” OR “endogenous testosterone” OR “serum testosterone” OR “circulating testosterone” OR “free testosterone” OR “total testosterone” OR “testosterone levels” OR androgen OR androgens OR “androgen deficiency” OR “androgen deprivation” OR hypogonadism OR hypogonadal OR dihydrotestosterone OR DHT OR “testosterone gel” OR “testosterone propionate” OR “testosterone enanthate”) AND (“default mode network” OR DMN OR “medial frontoparietal network” OR M-FPN OR “resting-state” OR “resting state” OR “functional connectivity” OR “brain connectivity” OR “network connectivity” OR “large-scale network” OR “intrinsic connectivity” OR “brain network” OR fMRI OR “functional MRI” OR “functional magnetic resonance imaging” OR “functional magnetic resonance” OR neuroimaging OR “brain imaging” OR “seed-based” OR “BOLD signal” OR “task-based fMRI” OR “task fMRI”) AND (cognit* OR “cognitive function” OR “cognitive performance” OR “cognitive decline” OR “cognitive impairment” OR “executive function” OR “executive control” OR “working memory” OR “episodic memory” OR “verbal memory” OR “spatial memory” OR “memory consolidation” OR attention OR “inhibitory control” OR “processing speed” OR “cognitive flexibility” OR “decision making” OR “self-referential” OR “self-referential processing” OR “social cognition” OR “theory of mind” OR mood OR “mood disorder” OR “emotional processing” OR “emotion regulation” OR affect OR “affective processing” OR “negative affect” OR “positive affect” OR depression OR “depressive symptoms” OR anxiety OR “well-being” OR wellbeing OR “quality of life” OR “emotional reactivity” OR “stress response” OR rumination OR “mind-wandering”). Additionally, manual internet and reference list searches of the included studies were conducted to identify studies outside of the database screening. No additional studies identified through manual searching were included in the present systematic review. Two independent reviewers were involved in the two-step screening process, including the initial title and abstract screening and full-text screening. Any discrepancies were resolved through discussion or third-party arbitration. Inclusion and exclusion criteria The exclusion criteria were applied to any secondary literature or studies with unreliable methods. Included studies assessed the DMN, measured testosterone, and reported cognitive or mood outcomes. Neuroimaging studies examining structures of the DMN without mentioning DMN in any part of the full text were excluded. The present review targeted studies that provided direct or indirect evidence of relationships between DMN, testosterone, and cognitive/mood domains to provide a wider analysis of this currently underexplored area. Only human studies were included to provide data for potential future clinical trials of testosterone modulation of the DMN. We included studies that assessed DMN activity and/or connectivity, without restricting inclusion to either measurement type. Data and outcomes extraction Two independent reviewers were involved in data extraction of the following information: authors, year, journal, title, study design, sample, brain imaging tools used, key findings, reported limitations, testosterone assessment/experimental manipulation methods, DMN-related findings, and Cognitive and Mood Domains. Any discrepancies were resolved through discussion. Risk of bias assessment Due to the variety of study designs, four risk of bias assessment tools were used, including the Cochrane risk-of-bias tool for randomized trials (RoB 2), the Newcastle–Ottawa Scale (NOS), the NIH Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies, and the AXIS tool. Randomized clinical trials (RCTs) were assessed using RoB 2. Prospective cohort studies were assessed using the NOS. Observational cohort and mixed observational studies were evaluated using the NIH Quality Assessment Tool, while purely cross-sectional studies were assessed using the AXIS tool. Overall judgments were standardized as low, moderate, or high risk of bias to allow consistent interpretation across the different assessment tools. Each risk-of-bias instrument uses a distinct scoring structure. Raw scores were not pooled numerically across tools. Instead, harmonization was achieved conceptually by mapping each instrument's domain-level or item-level judgments onto a common three-tier framework corresponding to low, moderate, and high overall risk of bias, consistent with recommended practice for evidence syntheses incorporating multiple study designs and their respective risk-of-bias instruments (). A study was classified as low risk when it satisfied the equivalent of all or nearly all quality domains on its respective tool, moderate risk when one or more domains raised specific yet non-critical concerns (e.g., inadequate confounding control, unclear blinding, or limited follow-up), and high risk when multiple domains, or a domain considered critical to internal validity (e.g., randomization integrity for RoB 2 or selection bias for the NOS and AXIS), were judged deficient. This qualitative mapping was selected in place of a numerical composite score, as neither RoB 2 nor comparable domain-based tools are intended to generate an overall score by summing individual item responses. The risk of bias assessment was performed by two independent reviewers, and any discrepancies were resolved through discussion or third-party arbitration. Results Study selection The initial PubMed database search yielded 531 records. Following the abstract and title screening process, 55 studies were extracted for full-text assessment. After full-text screening, 45 studies did not meet the inclusion criteria, resulting in 10 studies included in the present systematic review. A detailed overview of the selection process is presented in . Study characteristics The 10 included studies were published between 2014 and 2026 and comprised highly heterogeneous study designs, ranging from a densely sampled single-participant precision-imaging design to a large multimodal cohort of 3,024 adolescent females (; ; ; ; ; ; ; ; ; ). Samples included healthy adolescents and adults, transgender individuals undergoing sex-hormone treatment, current and former anabolic-androgenic steroid (AAS) users, women exposed to oral contraceptives, and females across the menstrual cycle. All studies used task-based fMRI or resting-state fMRI as neuroimaging methods, with one study additionally using structural MRI and diffusion MRI/DTI. Cognitive and mood outcomes were measured across working memory, peer evaluation, aggression/provocation, self-referential body perception, overall mood disturbance, and decision-making domains. Testosterone exposure was assessed using a variety of methods, including endogenous serum or salivary levels, fetal testosterone measured from amniotic fluid, exogenous testosterone administration, long-term anabolic-androgenic steroid exposure, cross-sex hormone treatment, and androgenic hormonal contraceptive exposure. Key limitations across most of the studies included small or single-sex samples and the absence of broader hormonal assessment (). Synthesis of DMN findings Adult men In current AAS users, a significant reduction in functional connectivity between the amygdala and DMN was observed, showing correlations with dose, dependency, on-cycle status, and an increased testosterone-to-epitestosterone ratio (). In a double-blind, placebo-controlled RCT, healthy males exposed to exogenous testosterone showed greater DMN activation during decision-making after social provocation compared with the control group, indicating testosterone involvement in DMN activity in the context of reactive aggression (). In the dense-sampling study of a single male, diurnal testosterone fluctuations showed negative associations with DMN connectivity, although the strongest hormone–brain associations were observed in non-DMN systems (). Adult women In female androgenic oral contraceptive (OC) users, alterations across anterior and posterior DMN components, particularly increased mPFC connectivity, were found relative to naturally cycling women (). Menstrual phase-related changes in posterior DMN regions, such as the temporal cortex and cuneus/precuneus, were also reported across the natural cycle (). Transgender adults undergoing gender-affirming hormone therapy In pretreatment transgender participants, weaker connectivity within the DMN was reported, particularly in the ACC, mPFC, precuneus, angular gyrus, and superior parietal cortex, compared with the cisgender control group (). Following cross-sex hormone treatment, DMN connectivity increased to levels comparable to those observed in the cisgender control group, showing no longer detectable differences at follow-up (). Adolescents and developmental populations Endogenous hormone studies in adolescent samples have provided a more complex sex-dependent pattern in DMN changes. Higher fetal testosterone levels predicted reduced connectivity between anterior cortical-midline and posterior DMN subsystems in adolescent males, whereas no such association was present in females (). Similar results remained significant when controlling for contemporaneous testosterone levels during adolescence (). During a spatial working memory task, adolescent girls showed greater deactivation of DMN regions, including the precuneus and anterior cingulate cortex, whereas boys demonstrated greater frontal cortex recruitment (). No significant mediating role of endogenous testosterone in sex differences was found (). Similarly, reported an association between higher salivary testosterone and stronger ACC deactivation during the working memory task in younger female participants, while higher testosterone in male participants was linked to increased precentral activation. In a large multimodal cohort study of early-adolescent females, testosterone was associated with increased connectivity between the DMN and its posterior subcomponent, the retrosplenial temporal network, alongside decreased connectivity between the DMN and both reward-related and control-related networks (). Notably, this study assessed testosterone alongside DHEA, and the authors interpreted the two androgens as jointly, rather than independently, related to brain structure, indicating that testosterone-specific attribution of these DMN findings cannot be fully disentangled from co-occurring DHEA exposure (). In contrast, no effect of testosterone on DMN connectivity was demonstrated in female adolescents during peer evaluation (). This study likewise measured pubertal testosterone and DHEA together, and reported that DHEA, rather than testosterone, was the androgen more consistently associated with reward-related network connectivity, again suggesting that testosterone's apparent lack of effect on the DMN in this sample should be interpreted alongside its shared variance with DHEA rather than in isolation (). Lastly, the dense-sampling study discussed above under adult men showed negative associations between DMN connectivity and testosterone levels, although the strongest hormone–brain associations were observed in non-DMN systems () (). Cognitive outcomes Associations between testosterone-related DMN changes and cognitive outcomes are synthesized below by sex, gender, and developmental/reproductive stage; overall, these associations were less consistent than the network-level alterations themselves (). Adult men No conventional cognitive-performance outcomes tied to DMN changes were reported for adult male samples among the included studies; behavioral outcomes in this group instead centered on affective reactivity and decision-making, addressed in Section 3.5.1 (; ; ). Adult women Even though cognitive changes in OC users were proposed to be influenced by large-scale brain networks, no direct link between testosterone-related DMN changes and cognitive function was found (). Transgender adults undergoing gender-affirming hormone therapy No conventional cognitive-performance outcomes were reported in relation to DMN changes in this population; reported outcomes instead centered on self-referential body perception, addressed in Section 3.5.3 (). Adolescents and developmental populations No sex differences in spatial working memory accuracy or reaction time were reported, even though divergence in neural recruitment was present, with girls showing greater DMN deactivation and boys greater frontal activation (). Likewise, found no correlation between testosterone-related DMN changes and cognitive control. In a study by , sex- and age-specific neural associations with testosterone during a working memory task were demonstrated. However, no testosterone-related performance advantage was reported (). In a large early-adolescent female cohort, testosterone-related structural and resting-state features were identified in regions implicated in visuospatial and executive processing, yet task-based emotional n-back activation was not associated with testosterone (). Moreover, dihydrotestosterone (DHT)-dysregulated genes were enriched for syndromic autism and intellectual disability and showed spatial expression patterns similar to the cortical midline DMN subsystem (). Affective and mood-related outcomes Adult men Testosterone administration was associated with increased DMN recruitment during aggressive decision periods, suggesting a possible role of testosterone in anger response modulation (). In AAS users with chronic supraphysiologic androgen exposure, reduced DMN-amygdala coupling was correlated with aggression, violence, and impulsivity (). In a single-male study, higher testosterone concentrations were associated with greater vigor and lower overall mood disturbance (). Adult women No direct link between testosterone-related DMN changes and affective or mood outcomes was demonstrated in OC users (). Transgender adults undergoing gender-affirming hormone therapy Improvement in own-body self-identification was positively associated with increased DMN connectivity in the precuneus/posterior cingulate region following hormone treatment, suggesting a link between testosterone-related network reorganization and self-referential body perception (). Adolescents and developmental populations No affective or mood-related outcomes tied to DMN changes were separately reported for the adolescent/developmental studies beyond the cognitive and network-level findings described above (; ; ; ; ). Overall, the included studies suggest that testosterone-related modulation of the DMN may be linked to self-referential processing, affective reactivity, and motivational state, while not being linked to conventional cognitive performance. Risk of bias Included studies ranged from low to high risk of bias, with most studies evaluated as being at moderate risk of bias. One study was judged to be at low risk of bias (), seven studies were rated as having moderate risk of bias (; ; ; ; ; ; ), and two studies were rated as high risk of bias (; ). Across tools, the most recurrent concerns related to limited sample-size justification, cross-sectional designs that constrained causal inference, incomplete adjustment for confounding, uncertainty regarding repeated exposure assessment or adequacy of follow-up, and restricted generalizability due to highly selected, sex-specific, or single-case samples. Detailed risk-of-bias assessment results are provided in the . Discussion The present systematic review synthesized evidence from ten neuroimaging studies exploring the relationships between testosterone and the DMN and the downstream implications for cognitive function and mood. Overall, the evidence yielded mixed findings, indicating the highly context-dependent, sex-specific, and androgen-exposure-sensitive role of testosterone-related DMN changes in cognitive and mood-related outcome domains. Cognitive outcomes From a developmental perspective, endogenous testosterone exhibited sex-specific DMN modulation (). Higher fetal testosterone levels predicted reduced connectivity between anterior and posterior DMN subsystems in adolescent males, but not in females, an effect that remained significant after controlling for contemporaneous testosterone levels, suggesting a potential contribution of testosterone to neurodevelopmental conditions involving social cognition deficits (). However, neither of the two studies evaluating sex differences found a correlation between testosterone-related DMN changes and working memory performance, despite demonstrating different localization patterns of DMN changes between sexes (; ). Connectivity between the DMN and other large-scale networks was also associated with testosterone levels, particularly increased within-DMN and DMN–retrosplenial temporal network connectivity, alongside decreased DMN coupling with reward-related and cognitive control networks (). These results, in which anterior DMN connectivity strengthens while cross-network integration decreases, may indicate a reconfigurative role of testosterone in the functional balance between internally directed and externally oriented processing streams regulated by the triple-network model (). As noted above, this interpretation is tempered by the co-assessment of DHEA in that sample, which limits attribution of these DMN changes to testosterone alone (). Still, found no relationship between pubertal testosterone levels and DMN connectivity during peer evaluation in adolescent females, and no association with cognitive control outcomes. Similarly, found no direct connection between testosterone modulation of the DMN and cognitive function. Collectively, these findings suggest that the cognitive consequences of testosterone-related DMN modulation depend on factors including sex, developmental stage, and hormonal context. Mood and affective outcomes Most studies reported testosterone-related effects on DMN regions involved in self-referential and affective processing, rather than on externally oriented cognitive performance. Chronic supraphysiologic androgen exposure in AAS users was associated with significantly reduced functional connectivity between the amygdala and the DMN, with the severity of disruption correlating with dose, dependency status, and the testosterone-to-epitestosterone ratio (). Given the well-established role of the amygdala–DMN axis in anxiety and threat appraisal (; ), this pattern of reduced coupling may account for the elevated aggression, impulsivity, and violence scores observed in AAS users in that study. Further reinforcing this hypothesis, the role of acute exogenous testosterone administration in aggressive decision-making via increased DMN recruitment was reported in a double-blind, placebo-controlled RCT (). In a transgender study, testosterone-related DMN reorganization was demonstrated (). Pretreatment individuals demonstrated weaker within-DMN connectivity, particularly in the ACC, mPFC, precuneus, angular gyrus, and superior parietal cortex, relative to cisgender controls (). Cross-sex hormone therapy resulted in DMN connectivity changes, making it indistinguishable from the cisgender baseline, while improving own-body self-identification (). These findings converge with prior evidence that DMN connectivity is integral to bodily self-consciousness and propose that testosterone may be one hormonal determinant of this process (). In a densely sampled male, diurnal testosterone fluctuations were negatively correlated with DMN connectivity and positively associated with vigor and lower mood disturbance scores (). However, other non-DMN networks showed a higher association with mood domains (), suggesting that the affective consequences of testosterone-related DMN modulation, like its cognitive consequences, depend on factors including sex, developmental stage, and hormonal context. The DMN operates within a broader triple-network framework alongside the salience and frontoparietal networks, whose coordinated interaction underlies complex cognitive and affective function and whose dysregulation is implicated across psychiatric and neurological conditions (). The salience network, anchored in the anterior insula, has been shown to detect behaviorally relevant stimuli and mediate switching between the DMN and the frontoparietal network (), a mechanism supported by causal modeling showing the anterior insula as a directed outflow hub whose inter-network influence predicts task performance (). Testosterone modulates connectivity beyond the DMN, for instance, exogenous administration reduced frontolimbic and frontoparietal connectivity in men (), and pubertal testosterone and DHEA were associated with salience-network and frontoparietal–reward connectivity during a socially salient task (). Recent findings of increased within-DMN connectivity and decreased DMN coupling with reward and cognitive control networks () suggest that testosterone-related DMN alterations may reflect a broader reorganization of salience and frontoparietal network engagement. Future work should model these networks jointly and apply effective connectivity approaches to determine whether testosterone acts primarily on the DMN or on the salience network's capacity to regulate it. Potential therapeutic implications of testosterone for cognitive performance and mood: benefits, risks, and limitations Cognitive performance Testosterone replacement therapy (TRT) is an established intervention for hypogonadism, a condition associated with fatigue, depressed mood, and impaired concentration (; ). Epidemiological evidence suggests an association between low bioavailable testosterone and cognitive impairment, deficits in processing speed, and an increased risk of dementia in older men, raising the question of whether restoration of physiological testosterone levels could mitigate age-related cognitive decline (; ). Moreover, individuals with amnestic mild cognitive impairment (aMCI) exhibit reduced functional connectivity within DMN regions (), including the mPFC, posterior cingulate cortex, and precuneus, which are among the regions most consistently affected by testosterone in the included studies. The neuroprotective role of testosterone has also been demonstrated at the cellular level through multiple converging mechanisms, including suppression of pro-inflammatory cytokines, reduction of oxidative stress via activation of antioxidant enzymes and upregulation of neurotrophic factors essential for neuronal maintenance (). Additionally, in preclinical models, testosterone has been shown to reduce amyloid-beta (Aβ) production, improve synaptic signaling, and counteract neuronal death (). Testosterone involvement in adult hippocampal neurogenesis through androgen-dependent pathways has recently been shown to enhance the survival of newly generated dentate gyrus neurons, with indirect involvement of brain-derived neurotrophic factor (BDNF) and glucocorticoid signaling (). In a recent clinical study, lower testosterone concentrations have been associated with higher amyloid burden and increased AD prevalence, underlining the potential role of testosterone supplementation in the protection of APOE4 carriers from tau pathology accumulation (). Androgen deprivation therapy (ADT), used to treat prostate cancer, provides consistent evidence of an association between testosterone and cognitive function (). Several studies have indicated an association between ADT and reductions in verbal and visuospatial memory, executive function, and processing speed, as well as mood changes, fatigue, and an increased risk of dementia (; ). In a cross-sectional neuroimaging study, ADT-related alterations in brain connectome structure were associated with cognitive decline (), accompanying the findings of the present systematic review regarding the role of large-scale brain networks in cognitive function and their modulation by testosterone. Findings from both ADT and TRT studies further strengthen the evidence associating testosterone with neuroprotective function and with brain connectivity, particularly within brain networks implicated in cognition and mood. However, the existing clinical evidence regarding these effects remains heterogeneous. For instance, a meta-analysis of RCTs in cognitively healthy older men found modest improvements in psychomotor speed and executive function in trials that successfully raised total testosterone levels, with no statistically significant effects on verbal memory or visuospatial ability (). In contrast, another RCT reported no improvement in memory or other cognitive functions in the group undergoing testosterone treatment compared with placebo (). Importantly, one study reported improvements in global cognitive composite scores in the testosterone group relative to placebo, suggesting the crucial role of metabolic and hormonal context in the cognitive benefits of TRT (). These discrepant findings reflect the heterogeneity of sample characteristics. Therefore, future randomized controlled trials assessing DMN connectivity in the context of testosterone effects should consider measuring the broader hormonal and metabolic profile of patients. The relationship between testosterone and cognition appears to vary across the human lifespan, highlighting the important role of androgen hormones in early-age neurodevelopment and cognitive maintenance in the elderly population (). During puberty, testosterone is associated with neuroarchitectural development in a sex-specific manner, particularly in subcortical and prefrontal structures, which may influence executive function, reward processing, and working memory (). Moreover, one systematic review reported sex-specific functional reorganization of higher-order cognitive circuits following pubertal androgen exposure (). Population-level data from the UK Biobank, covering 159,411 community-dwelling men followed for a median of seven years, indicated a 43% higher risk of incident all-cause dementia and an 80% greater risk of Alzheimer's disease in men within the lowest testosterone quintile compared to those in the highest quintile (). Additionally, a meta-analysis of 27 studies reported a significant association between declining total testosterone and elevated all-cause dementia risk (). Higher total and free testosterone levels were associated with higher scores in episodic memory and processing speed assessments in older men, while no association between testosterone and cognitive task performance was found in an age-matched women group (). However, this sex specificity is further complicated by genotype. For instance, in older women, lower testosterone was associated with poorer global cognition, processing speed, and verbal memory among APOE-ε4 carriers only (). A recent longitudinal study demonstrated a more complex relationship between testosterone and cognition in women, with higher testosterone levels linked to poorer visuoconstruction and verbal fluency (). These findings suggest a crucial and complex connection between testosterone and cognitive function in both men and women across the lifespan. Mood Studies by and provide evidence that testosterone-related DMN changes may accompany mood improvement. These observations are consistent with broader evidence of DMN hyperconnectivity normalization mechanisms mediated by antidepressants () and with DMN dysregulation as a potential mechanism underlying mood disorders (). Clinically, testosterone treatment was associated with significant reductions in depressive symptoms in men across a broad age range, manifesting more robustly in hypogonadal populations (). Despite the large amount of evidence, several significant risks and limitations substantially constrain the therapeutic utility of testosterone-based interventions. For instance, evidence from AAS users demonstrated increased aggression, impulsivity, and violence associated with the effects of supraphysiological testosterone exposure on DMN-amygdala connectivity (). The divergent DMN responses to testosterone levels imply the need for sex-tailored and individualized approaches in dosing protocols (; ; ). Another TRT risk is testosterone-induced erythrocytosis, which elevates blood viscosity and is associated with an increased risk of major adverse cardiovascular events (MACE) and venous thromboembolic events (VTE) in the first year of TRT, particularly when hematocrit rises substantially (). According to the Endocrine Society guidelines, TRT should be avoided in men with a baseline hematocrit above 50% (). Limitations and future directions Several limitations of this review should be acknowledged. First, only PubMed was searched, a decision specified a priori in the PROSPERO registration. We recognize that multi-database searching is generally recommended to minimize the risk of missing eligible studies. However, several features of the present review reduce this risk. PubMed/MEDLINE indexes the great majority of biomedical and neuroimaging journals relevant to this topic. The search string also used extensive synonym expansion across all three concept domains (testosterone/androgen exposure, DMN/connectivity terminology, and cognitive/mood outcomes), increasing sensitivity within the single database searched and we supplemented this with manual reference-list screening of all included studies, which did not identify additional eligible records. Nonetheless, databases such as Embase, Scopus, Web of Science, and PsycINFO index additional journals not captured by PubMed and their omission remains a limitation that could affect the findings of this review. Second, the search was restricted to studies published in English. This restriction was applied for practical reasons: it allowed both reviewers to directly assess study eligibility, extract data, and appraise risk of bias without relying on translation, which would have introduced additional resource requirements and potential translation-related error into the screening and extraction process. We acknowledge that this restriction may have excluded relevant non-English studies, particularly given that testosterone-DMN research is an active area internationally, and that this introduces a potential source of language bias into the review. We report both limitations explicitly and recommend that future updates of this review incorporate multi-database, multi-language search strategies to verify the stability of the present synthesis. Only ten studies met the inclusion criteria, reflecting the limited and emerging nature of research on testosterone, DMN connectivity, and cognitive or mood outcomes. Secondly, due to the heterogeneity of the included studies (e.g., different testosterone exposures, wide variation in age, sex, and hormonal status among study populations), no meta-analysis was conducted, limiting direct comparability. Additionally, many studies did not assess the broader hormonal environment, including estradiol and other sex hormones that interact with testosterone, thereby reducing confidence in attributing the observed neural effects specifically to testosterone. This is a substantial limitation, since several endocrine variables beyond circulating testosterone itself are known to shape DMN and other large-scale network connectivity and were not consistently measured or controlled for across the included studies. A meaningful proportion of testosterone's central effects are mediated indirectly through aromatization to estradiol, and dense-sampling neuroimaging work has shown that day-to-day fluctuations in estradiol across the menstrual cycle drive reorganization of cortical networks, with especially pronounced effects in DMN hubs that are densely populated with estrogen receptors (). Brain aromatase converts testosterone into estradiol locally within DMN-relevant regions such as the hippocampus, amygdala, and cortex, meaning androgen-only assessment may fail to capture the estrogenic pathway through which testosterone influences neural connectivity (). Cortisol is another relevant confound, as experimental cortisol administration alters resting-state connectivity of the DMN and its coupling with the salience network, indicating that unmeasured hypothalamic-pituitary-adrenal axis activity could confound testosterone-DMN associations (). Similarly, circadian and diurnal variation in steroid hormone secretion, menstrual cycle phase, and DHEA levels were inconsistently reported or controlled for across the included studies, further limiting the ability to isolate testosterone-specific effects on DMN connectivity from these co-varying endocrine influences. Finally, many studies were considered to have a moderate or high risk of bias, mainly due to small sample sizes and imbalanced sex representation. Future research should focus on longitudinal and randomized studies, balanced participant representation, and comprehensive hormonal profiling that extends beyond testosterone alone to include estradiol, sex hormone-binding globulin (SHBG), cortisol, DHEA, menstrual cycle phase, circadian sampling time, and indices of testosterone aromatization, given the demonstrated influence of these endocrine variables on functional connectivity. Preregistration and standardized reporting practices may also improve reproducibility and help clarify the causal role of testosterone in DMN-related cognitive and mood changes. Conclusion This systematic review characterized the neurobiological effects of testosterone on DMN organization, demonstrating alterations in functional connectivity across key DMN hubs involved in self-referential processing, including the medial prefrontal cortex, anterior cingulate cortex, precuneus, and angular gyrus. However, the directionality and behavioral relevance of these effects varied according to sex, developmental stage, and the magnitude and context of androgen exposure, underscoring the complexity of testosterone-mediated neural modulation. Across the included studies, testosterone-related DMN alterations were more consistently associated with affective and self-related processes, including mood regulation, aggression, and body self-identification, whereas associations with externally oriented cognitive functions remained limited. These findings position the DMN as a potential neural substrate underlying testosterone-dependent modulation of affective regulation and self-processing, while broader cognitive effects likely involve additional mechanisms beyond DMN connectivity changes. Despite its potential implications for understanding testosterone-related behavioral and clinical phenotypes, the current evidence remains constrained by methodological heterogeneity, limited endocrine characterization, and the predominance of observational designs. Future longitudinal and randomized investigations integrating comprehensive hormonal profiling with multimodal network analyses will be required to clarify the causal mechanisms underlying testosterone-induced alterations in brain network organization and their relevance for cognitive and mood-related disorders.